A Medical Science Liaison (MSL) is a field-based, doctorate-level scientific role inside pharmaceutical, biotechnology, medical device and CRO organizations. MSLs build peer-to-peer relationships with Key Opinion Leaders (KOLs) — leading physicians and researchers at academic and clinical institutions — and serve as the scientific bridge between a company’s clinical/research data and the external medical community. For researchers considering a move out of the lab or the clinic, the MSL role is one of the most common landing points: it uses deep therapeutic-area expertise and the ability to translate complex data for a non-authorship audience, without requiring a switch into sales.
This page covers what the role actually involves day to day, why it is structurally separated from commercial functions, what hiring managers screen for, how a postdoc or clinical background translates (and where it does not), the typical career ladder, and how the role differs from adjacent clinical-research positions such as the Clinical Research Associate (CRA) and the medical writer.
What an MSL Actually Does Day to Day
The job is built around scientific exchange, not transaction. Core activities include:
- KOL engagement. Identifying, meeting with, and maintaining long-term scientific relationships with leading investigators and clinicians in a defined therapeutic area and geography — discussing disease state, emerging data, and unmet need, in both directions.
- Scientific exchange. Responding to unsolicited requests from healthcare providers for in-depth clinical and mechanistic data that goes beyond approved labeling — this is the activity that most clearly separates medical affairs from a promotional interaction.
- Advisory boards. Organizing and supporting scientific advisory boards where external experts give structured feedback on clinical development plans, unmet need, or real-world evidence gaps.
- Congress coverage. Attending medical conferences to gather competitive intelligence, support company-sponsored scientific sessions, and meet with KOLs in a less formal setting.
- Field medical insights. Synthesizing what is heard in the field — unmet needs, perceptions of a therapy’s evidence base, investigator interest in future trials — into structured reports that inform medical affairs strategy, publication planning, and (indirectly, through proper channels) clinical development.
- Clinical trial support. Depending on the company, MSLs may support site identification and investigator engagement for company-sponsored trials, though they are not typically the trial’s operational point of contact — that role belongs to the clinical research associate.
The Medical Affairs / Commercial Firewall
The MSL role exists, structurally, because of a regulatory distinction: promotional communication about a drug or device is restricted to on-label, approved claims and is the domain of sales and marketing, while non-promotional scientific exchange — including responses to unsolicited off-label questions from healthcare providers — is permitted under a separate compliance framework. Pharmaceutical and device compliance programs (shaped by U.S. Office of Inspector General guidance, the FDA’s rules on off-label communication, and industry codes such as the PhRMA Code) generally require that medical affairs, including MSLs, report through a separate chain from commercial/sales, avoid compensation tied to sales performance, and avoid attending sales calls or being present for promotional discussions.
This is the single most common thing people outside the industry misunderstand about the role: an MSL is not a “scientific salesperson.” A well-run medical affairs function treats that firewall as a compliance-critical structural feature, not a courtesy, and MSL training typically includes explicit instruction on what an MSL can and cannot say, and when a question must be redirected to regulatory-approved promotional material or escalated through medical information channels instead.
Entry Requirements
The MSL role has become a doctorate-standard field. According to MSL Society survey data, a large majority of current MSLs hold a doctoral degree — PharmD, PhD, or MD being the three most common credentials, with PharmD and PhD roughly comparable in prevalence and MD less common. A master’s-level scientist can still enter the field, particularly with strong therapeutic-area depth or prior clinical/industry experience, but the doctorate has become the norm rather than the exception, especially at larger companies.
Beyond the degree itself, hiring managers for MSL roles are typically screening for:
- Therapeutic-area depth that matches the company’s product portfolio — a postdoc or clinical fellowship spent in the relevant disease area is a strong signal, often stronger than the degree type itself.
- Communication under scrutiny. The ability to present complex data clearly to a skeptical, expert audience (a KOL interview or mock scientific exchange is a common interview exercise) and to do so without straying into promotional language.
- Field readiness. Willingness and ability to travel regularly within an assigned territory, since the role is field-based rather than office-based at most companies.
- Compliance literacy. An understanding, or the demonstrated ability to quickly learn, the regulatory boundaries around off-label discussion, fair balance, and the separation from commercial activity described above.
- Relationship-building temperament. The role rewards patience and long-horizon relationship management over transactional persuasion — a different skill set than sales, even though outsiders often conflate the two.
Transitioning from Academia or the Clinic
Postdoctoral researchers, clinical fellows, and PharmD residents are the most common feeder population for entry-level MSL roles. What tends to translate directly:
- Deep, current knowledge of a specific disease area or mechanism, especially if it overlaps with an active area of drug development.
- Experience presenting to and fielding tough questions from expert audiences — conference talks, thesis defenses, grand rounds, and journal clubs are all reasonable proxies.
- Experience critically appraising clinical and preclinical literature, since the job involves constant, rapid synthesis of new publications and unpublished data.
- An existing professional network within the therapeutic area, which shortens the ramp-up time considerably.
What tends not to translate automatically, and is worth being honest about before applying:
- Academic writing and presentation habits built around exhaustive detail and hedged conclusions do not map cleanly onto the concise, audience-calibrated communication style the role demands.
- Grant-writing and bench experience are only weakly relevant unless paired with genuine clinical or disease-area fluency — a strictly basic-science PhD without translational exposure is a harder sell than one with clinical trial or patient-facing experience.
- Comfort with a metrics-driven, field-sales-adjacent employer culture (KOL engagement targets, CRM documentation, territory management) is a real adjustment for people coming directly from a university lab.
Most companies run structured MSL onboarding or fellowship programs (some pharmaceutical companies run formal 12-to-24-month MSL fellowships aimed specifically at PharmD graduates and postdocs) that are worth researching directly, since program structure and expectations vary considerably by company and therapeutic area.
Career Ladder
The typical progression, though titles and timelines vary by company:
- Medical Science Liaison (entry-level). Individual contributor, assigned territory and therapeutic area.
- Senior MSL. Broader territory or product scope, often mentoring newer MSLs.
- MSL Manager / Regional Field Medical Director. People-management of an MSL team, still closely tied to field strategy.
- Director / Senior Director, Field Medical or Medical Affairs. Cross-functional leadership spanning multiple therapeutic areas or the full field medical function.
- VP / Executive Medical Affairs leadership. Sets medical affairs strategy at the company or portfolio level; this tier typically requires either an MD or extensive PharmD/PhD industry leadership experience.
Lateral moves are also common and often used deliberately as career-broadening steps: MSLs move into medical information, publications, health economics and outcomes research (HEOR), clinical development/medical monitoring, or, less often, back toward clinical research operations.
MSL vs. Clinical Research Associate vs. Medical Writer
These three roles are the ones researchers most often confuse, since all three sit at the interface of clinical data and industry, and all three commonly recruit from PhD/PharmD/clinical backgrounds. They are structurally distinct jobs.
| Dimension | Medical Science Liaison | Clinical Research Associate (CRA) | Medical Writer |
|---|---|---|---|
| Primary function | Scientific exchange with external KOLs; field medical strategy | Monitoring trial sites for protocol and GCP compliance | Drafting clinical study reports, manuscripts, regulatory and scientific documents |
| Where the work happens | Field-based; KOL offices, conferences, advisory boards | Field-based; investigator sites, monitoring visits | Office/remote-based; document production |
| Relationship to a specific trial | Indirect; supports strategy, not day-to-day trial conduct | Direct; the operational point of contact for assigned sites | Direct; produces the trial’s written outputs (CSRs, protocols, manuscripts) |
| Typical entry credential | PharmD, PhD, or MD (doctorate-standard) | Bachelor’s or master’s in life sciences; CRA-specific certification common | Bachelor’s through PhD; AMWA/EMWA certification common (see AMWA Certified Medical Writer) |
| Commercial contact | Structurally firewalled from sales | Not commercially aligned; operationally focused | Not commercially aligned; document-focused |
| Typical career next step | Senior MSL, field medical management, medical affairs leadership | Senior CRA, clinical trial manager, project management | Senior/principal medical writer, regulatory writing lead |
See also how the CRA role compares to the closely related clinical research coordinator role in Clinical Research Coordinator vs. Clinical Research Associate, and what a Clinical Research Associate (CRA) does in practice.
Compensation
MSL compensation varies substantially by therapeutic area, company size, geography, and years of experience, and CASRAI does not publish specific salary figures here because there is no single verifiable authoritative source that stays current across all of those variables. If compensation research is part of your decision, cross-reference multiple current sources — industry salary surveys published by organizations such as the MSL Society, recruiter-published market data, and job postings with disclosed salary ranges where required by local pay-transparency law — rather than relying on any single figure.
Frequently Asked Questions
Do you need a PhD to become a medical science liaison?
Not strictly, but a doctoral degree (PharmD, PhD, or MD) has become the norm for the role rather than the exception, particularly at larger companies. Candidates without a doctorate can still enter the field, usually with strong therapeutic-area experience or a master’s degree paired with relevant clinical or industry background.
Is a medical science liaison a sales job?
No. MSLs are structurally separated from sales and commercial functions specifically so they can engage in non-promotional scientific exchange, including answering unsolicited off-label questions from healthcare providers — an activity sales representatives are not permitted to conduct. Compliance frameworks typically require a separate reporting line, non-sales-based compensation, and no attendance at promotional activities.
Can a postdoc become an MSL without industry experience?
Yes, this is one of the most common entry paths. What matters most is therapeutic-area depth that matches a company’s portfolio, experience communicating complex data to expert audiences, and comfort with a field-based, relationship-driven role. Many companies also run structured MSL fellowship or onboarding programs aimed specifically at candidates moving from academia or clinical training.
What is the difference between an MSL and a clinical research associate?
A CRA is the operational point of contact for a specific clinical trial, responsible for site monitoring and protocol/GCP compliance. An MSL is not tied to day-to-day trial operations; the role is centered on ongoing scientific relationships with external experts and field medical strategy. See the comparison table above for the full breakdown.
What does an MSL career path look like after several years in the role?
The most common path is Senior MSL, then people-management of a field medical team (MSL Manager or Regional Field Medical Director), then broader Director/Senior Director-level medical affairs leadership. Lateral moves into medical information, HEOR, publications, or clinical development are also common and are often used deliberately to broaden experience before pursuing a leadership track.
For the broader clinical research administration landscape this role sits within, see the CASRAI Clinical Research Administration pillar guide. For the regulatory framework MSLs and clinical teams are both expected to understand, see Good Clinical Practice (GCP) and the dictionary entry on ICH GCP. For a comparable “what does this role actually do” breakdown of another clinical research position, see What Does a Principal Investigator Do? and What Does a Clinical Research Coordinator Do?
